DE69302580D1 - Vernetztes polyhydroxyl-material zur enzymatisch gesteuerten arzneistofffreisetzung - Google Patents

Vernetztes polyhydroxyl-material zur enzymatisch gesteuerten arzneistofffreisetzung

Info

Publication number
DE69302580D1
DE69302580D1 DE69302580T DE69302580T DE69302580D1 DE 69302580 D1 DE69302580 D1 DE 69302580D1 DE 69302580 T DE69302580 T DE 69302580T DE 69302580 T DE69302580 T DE 69302580T DE 69302580 D1 DE69302580 D1 DE 69302580D1
Authority
DE
Germany
Prior art keywords
amylase
alpha
cross
crosslinked
drug release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69302580T
Other languages
English (en)
Other versions
DE69302580T2 (de
Inventor
Mircea A Mateescu
Yves Dumoulin
Louis Cartilier
Vincent Lenaerts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Labopharm Inc
Original Assignee
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc filed Critical Labopharm Inc
Application granted granted Critical
Publication of DE69302580D1 publication Critical patent/DE69302580D1/de
Publication of DE69302580T2 publication Critical patent/DE69302580T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69302580T 1992-07-24 1993-07-22 Vernetztes polyhydroxyl-material zur enzymatisch gesteuerten arzneistofffreisetzung Expired - Lifetime DE69302580T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91976292A 1992-07-24 1992-07-24
PCT/CA1993/000298 WO1994002121A1 (en) 1992-07-24 1993-07-22 Cross-linked polyhydroxylic material for enzymatically controlled drug release

Publications (2)

Publication Number Publication Date
DE69302580D1 true DE69302580D1 (de) 1996-06-13
DE69302580T2 DE69302580T2 (de) 1996-09-26

Family

ID=25442612

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69302580T Expired - Lifetime DE69302580T2 (de) 1992-07-24 1993-07-22 Vernetztes polyhydroxyl-material zur enzymatisch gesteuerten arzneistofffreisetzung

Country Status (18)

Country Link
EP (1) EP0651634B1 (de)
JP (1) JP3647859B2 (de)
KR (1) KR100304997B1 (de)
AT (1) ATE137668T1 (de)
AU (1) AU668198B2 (de)
CA (1) CA2140032C (de)
CZ (1) CZ283395B6 (de)
DE (1) DE69302580T2 (de)
ES (1) ES2086949T3 (de)
FI (1) FI950301A0 (de)
GR (1) GR3020476T3 (de)
HU (1) HU221591B (de)
MX (1) MX9304459A (de)
NO (1) NO308024B1 (de)
NZ (1) NZ254048A (de)
PL (1) PL173249B1 (de)
RU (1) RU2136270C1 (de)
WO (1) WO1994002121A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2173818A1 (fr) * 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
DE19640062B4 (de) * 1996-09-28 2006-04-27 Lts Lohmann Therapie-Systeme Ag Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff
US5879707A (en) * 1996-10-30 1999-03-09 Universite De Montreal Substituted amylose as a matrix for sustained drug release
US5807575A (en) * 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
ZA984336B (en) * 1997-05-21 1998-11-30 Warner Lambert Co Non-sedating acrivastine product
CA2217238C (en) * 1997-10-24 2005-09-20 Louis Cartilier Cross-linked cellulose as a tablet excipient
IL150053A0 (en) 1999-12-06 2002-12-01 Mendell Co Inc Edward Pharmaceutical superdisintegrant
US6607748B1 (en) 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
DK1940467T3 (da) 2005-09-09 2017-02-13 Paladin Labs Inc Lægemiddelsammensætning med langvarig frigivelse
EP1946780B1 (de) 2005-11-11 2012-01-11 Asahi Kasei Chemicals Corporation Feste zubereitung mit kontrollierter freisetzung
BR112013000190A2 (pt) 2010-07-06 2017-11-07 Gruenenthal Gmbh formas de dosagem de retenção gástrica compreendendo um análogo de gaba e um opioide
WO2012007159A2 (en) 2010-07-14 2012-01-19 Grünenthal GmbH Novel gastro-retentive dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3181998A (en) * 1960-08-12 1965-05-04 Joseph L Kanig Tablet disintegration
US3493652A (en) * 1962-09-14 1970-02-03 Charles W Hartman Controlled release medicament
SE420565B (sv) * 1974-06-06 1981-10-19 Pharmacia Ab Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel
DE3721574A1 (de) * 1987-06-30 1989-01-12 Kettelhack Riker Pharma Gmbh Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung

Also Published As

Publication number Publication date
HU9500197D0 (en) 1995-03-28
ATE137668T1 (de) 1996-05-15
EP0651634B1 (de) 1996-05-08
NO950251D0 (no) 1995-01-23
ES2086949T3 (es) 1996-07-01
WO1994002121A1 (en) 1994-02-03
NZ254048A (en) 1995-09-26
EP0651634A1 (de) 1995-05-10
FI950301A (fi) 1995-01-24
DE69302580T2 (de) 1996-09-26
CZ283395B6 (cs) 1998-04-15
KR100304997B1 (ko) 2002-04-24
GR3020476T3 (en) 1996-10-31
CA2140032C (en) 1999-01-26
PL173249B1 (pl) 1998-02-27
JP3647859B2 (ja) 2005-05-18
HUT75673A (en) 1997-05-28
PL307234A1 (en) 1995-05-15
JPH08502036A (ja) 1996-03-05
NO950251L (no) 1995-01-23
RU2136270C1 (ru) 1999-09-10
CA2140032A1 (en) 1994-02-03
CZ15295A3 (en) 1995-09-13
AU4555993A (en) 1994-02-14
AU668198B2 (en) 1996-04-26
MX9304459A (es) 1994-04-29
HU221591B (hu) 2002-11-28
FI950301A0 (fi) 1995-01-24
NO308024B1 (no) 2000-07-10

Similar Documents

Publication Publication Date Title
DE69302580D1 (de) Vernetztes polyhydroxyl-material zur enzymatisch gesteuerten arzneistofffreisetzung
PT954290E (pt) Comprimido farmaceutico de libertacao controlada contendo um suporte a base de amilose reticulada e de hidroxipropilmetilcelulose.
FI973419A (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
FI954232A0 (fi) Siiloitettu amyloosi sideaineena/hajotusaineena tableteissa
DK1032376T3 (da) Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelse
NO20001042L (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
BR9609033B1 (pt) composição e emulsão para a liberação controlada de uma substáncia.
ES2162922T3 (es) Composicion para administracion colonica de medicamentos.
ATE187640T1 (de) Arzneimittel in tablettenform mit verzögerter wirkstoffabgabe auf basis von hochmolekularen polysaccharidgranulaten
DE59504270D1 (de) Retardtablette mit einem gehalt an diclofenac-na
DE69225053D1 (de) Zusammensetzungen auf der basis von collagen zur kontrollierten arzneistoffreisetzung
DK0804165T3 (da) Fast lægemiddelform med aktivt stof fordelt i polymert materiale
NO991047D0 (no) Transdermal terapeutisk tilnµrming involverende en kombinasjon av aktive substanser inneholdende °striol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: WITTE, WELLER & PARTNER, 70178 STUTTGART